Free Trial

Astera Labs (NASDAQ:ALAB) Price Target Raised to $200.00 at Deutsche Bank Aktiengesellschaft

Astera Labs logo with Computer and Technology background

Key Points

  • Deutsche Bank Aktiengesellschaft has raised its price target for Astera Labs (NASDAQ:ALAB) from $160.00 to $200.00, indicating a potential upside of 18.33% from the current price, while maintaining a "buy" rating.
  • Multiple analysts, including Evercore ISI and Morgan Stanley, have also increased their target prices for Astera Labs, with estimates ranging up to $215.00, reflecting strong overall market confidence in the stock.
  • Astera Labs reported $0.44 earnings per share for the quarter, exceeding estimates and demonstrating a 149.5% increase in year-over-year revenue, highlighting significant growth potential.
  • MarketBeat previews the top five stocks to own by October 1st.

Astera Labs (NASDAQ:ALAB - Get Free Report) had its price objective hoisted by equities researchers at Deutsche Bank Aktiengesellschaft from $160.00 to $200.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage currently has a "buy" rating on the stock. Deutsche Bank Aktiengesellschaft's target price points to a potential upside of 18.33% from the company's current price.

A number of other equities research analysts also recently issued reports on ALAB. Evercore ISI increased their target price on shares of Astera Labs from $104.00 to $215.00 and gave the stock an "outperform" rating in a research report on Wednesday, August 6th. Stifel Nicolaus set a $145.00 price objective on Astera Labs and gave the stock a "buy" rating in a report on Monday, August 4th. Susquehanna boosted their target price on Astera Labs from $80.00 to $125.00 and gave the company a "neutral" rating in a research note on Thursday, August 7th. Morgan Stanley upped their target price on Astera Labs from $155.00 to $200.00 and gave the stock an "overweight" rating in a research report on Friday. Finally, Barclays reiterated an "overweight" rating and set a $155.00 price target (up from $75.00) on shares of Astera Labs in a report on Thursday, August 7th. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $142.00.

Get Our Latest Stock Report on ALAB

Astera Labs Stock Performance

NASDAQ:ALAB traded down $13.18 during trading hours on Tuesday, hitting $169.02. 3,347,197 shares of the company's stock traded hands, compared to its average volume of 4,918,959. The stock's fifty day moving average price is $134.36 and its two-hundred day moving average price is $96.42. The firm has a market cap of $28.10 billion, a P/E ratio of 301.52, a P/E/G ratio of 4.62 and a beta of 1.46. Astera Labs has a twelve month low of $36.85 and a twelve month high of $199.47.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.33 by $0.11. The company had revenue of $191.93 million for the quarter, compared to analysts' expectations of $172.46 million. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The business's revenue for the quarter was up 149.5% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.13 EPS. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. On average, equities research analysts predict that Astera Labs will post 0.34 earnings per share for the current year.

Insider Buying and Selling at Astera Labs

In related news, CEO Jitendra Mohan sold 152,517 shares of the company's stock in a transaction on Thursday, August 7th. The shares were sold at an average price of $170.33, for a total transaction of $25,978,220.61. Following the completion of the sale, the chief executive officer directly owned 450,001 shares of the company's stock, valued at approximately $76,648,670.33. This represents a 25.31% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Sanjay Gajendra sold 280,000 shares of Astera Labs stock in a transaction on Thursday, August 7th. The stock was sold at an average price of $170.02, for a total transaction of $47,605,600.00. Following the completion of the transaction, the chief operating officer owned 5,525,545 shares in the company, valued at $939,453,160.90. This trade represents a 4.82% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 1,728,116 shares of company stock worth $239,272,181 over the last 90 days. Insiders own 12.50% of the company's stock.

Institutional Investors Weigh In On Astera Labs

A number of hedge funds have recently bought and sold shares of the company. Oliver Lagore Vanvalin Investment Group bought a new position in shares of Astera Labs in the second quarter worth about $29,000. Bernard Wealth Management Corp. bought a new stake in Astera Labs during the 2nd quarter valued at approximately $36,000. Clearstead Trust LLC grew its holdings in Astera Labs by 46,100.0% in the 2nd quarter. Clearstead Trust LLC now owns 462 shares of the company's stock valued at $42,000 after buying an additional 461 shares during the last quarter. Advisors Asset Management Inc. increased its position in Astera Labs by 68.6% in the 2nd quarter. Advisors Asset Management Inc. now owns 477 shares of the company's stock worth $43,000 after buying an additional 194 shares during the period. Finally, Manchester Capital Management LLC lifted its holdings in shares of Astera Labs by 141.5% during the second quarter. Manchester Capital Management LLC now owns 483 shares of the company's stock worth $44,000 after buying an additional 283 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Company Profile

(Get Free Report)

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Featured Stories

Analyst Recommendations for Astera Labs (NASDAQ:ALAB)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Astera Labs Right Now?

Before you consider Astera Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.

While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

September Rate Cuts: 3 Stocks Set to Benefit Most
Markets Are Sliding: Where to Find Opportunity
5 Hot Stocks to Buy Now: September’s Top Picks With Major Momentum

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines